Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C

Author:

Eckel-Passow Jeanette E1,Drucker Kristen L1,Kollmeyer Thomas M2,Kosel Matt L11,Decker Paul A11,Molinaro Annette M34ORCID,Rice Terri3,Praska Corinne E2,Clark Lauren2,Caron Alissa2,Abyzov Alexej1,Batzler Anthony1,Song Jun S5,Pekmezci Melike6,Hansen Helen M3,McCoy Lucie S3,Bracci Paige M1,Wiemels Joseph4,Wiencke John K347,Francis Stephen34,Burns Terry C8,Giannini Caterina2,Lachance Daniel H29,Wrensch Margaret347,Jenkins Robert B2

Affiliation:

1. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota

2. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota

3. Department of Neurological Surgery, University of California San Francisco (UCSF), San Francisco, California

4. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California

5. Department of Physics, Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Champaign, Illinois

6. Department of Pathology, University of California San Francisco, San Francisco, California

7. Institute of Human Genetics, University of California San Francisco, San Francisco, California

8. Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota

9. Department of Neurology, Mayo Clinic, Rochester, Minnesota

Abstract

Abstract Background Twenty-five germline variants are associated with adult diffuse glioma, and some of these variants have been shown to be associated with particular subtypes of glioma. We hypothesized that additional germline variants could be identified if a genome-wide association study (GWAS) were performed by molecular subtype. Methods A total of 1320 glioma cases and 1889 controls were used in the discovery set and 799 glioma cases and 808 controls in the validation set. Glioma cases were classified into molecular subtypes based on combinations of isocitrate dehydrogenase (IDH) mutation, telomerase reverse transcriptase (TERT) promoter mutation, and 1p/19q codeletion. Logistic regression was applied to the discovery and validation sets to test for associations of variants with each of the subtypes. A meta-analysis was subsequently performed using a genome-wide P-value threshold of 5 × 10−8. Results Nine variants in or near D-2-hydroxyglutarate dehydrogenase (D2HGDH) on chromosome 2 were genome-wide significant in IDH-mutated glioma (most significant was rs5839764, meta P = 2.82 × 10−10). Further stratifying by 1p/19q codeletion status, one variant in D2HGDH was genome-wide significant in IDH-mutated non-codeleted glioma (rs1106639, meta P = 4.96 × 10−8). Further stratifying by TERT mutation, one variant near FAM20C (family with sequence similarity 20, member C) on chromosome 7 was genome-wide significant in gliomas that have IDH mutation, TERT mutation, and 1p/19q codeletion (rs111976262, meta P = 9.56 × 10−9). Thirty-six variants in or near GMEB2 on chromosome 20 near regulator of telomere elongation helicase 1 (RTEL1) were genome-wide significant in IDH wild-type glioma (most significant was rs4809313, meta P = 2.60 × 10−10). Conclusions Performing a GWAS by molecular subtype identified 2 new regions and a candidate independent region near RTEL1, which were associated with specific glioma molecular subtypes.

Funder

National Institutes of Health

Bernie and Edith Waterman Foundation

Ting Tsung and Wei Fong Chao Family Foundation

National Brain Tumor Society

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3